Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

New genetic discoveries in alopecia areata could lead to better treatments.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

A mutation in the IL2RA gene increases the risk of alopecia areata.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

A 22-year-old with multiple autoimmune diseases needs a multidisciplinary treatment approach.

Targeting Vδ1+T-cells may help treat alopecia areata.

Overexpression of IKZF1 and Ikaros causes hair loss in mice similar to alopecia areata.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Most kids with alopecia areata have other health issues, often allergies or skin conditions.

Blocking LFA-1 prevents hair loss in mice.

Alopecia areata may protect against graft dysfunction, while asthma may increase its risk.

HLA-DRB5 and other genes may be linked to alopecia universalis.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

People with alopecia areata are more likely to have thyroid autoimmunity, but not thyroid disease.

Higher CRBP1 levels are linked to more severe alopecia areata.